To investigate the molecular signatures underlying disease progression across BC subtypes, we conducted a comparative intersection analysis of differentially expressed genes (DEGs) (34) identified in three endothelial cell subclasses (EC4, EC5 and EC6) derived from ER, HER2, and ER_LN breast malignancies relative to normal counterparts. This evidence concerns the gene ERBB2 and breast cancer.